Karyopharm therapeutics reports q1 loss per share of $0.78

Karyopharm reports first quarter 2020 financial results and highlights recent company progress.q1 loss per share $0.78.q1 earnings per share estimate $-0.69 -- refinitiv ibes data.net product revenue for q1 of 2020 was $16.1 million..

KPTI Ratings Summary

KPTI Quant Ranking